Oncimmune Holdings PLC (LON:ONC) chief executive Dr Adam Hill speaks to Proactive London as the firm announced the positive results of a large-scale lung cancer study.
The company’s EarlyCDT-Lung test was used alongside x-rays and CT scans to check for the disease.
A total of 12,210 people in Scotland were monitored for two years as part of the Early Cancer Detection Test in what is believed to be the largest randomised controlled assessment of its kind.
Original Article: Oncimmune reports successful large-scale lung cancer study